Vimarsana
Biggest News Aggregation in the World

Page 42 - Patrick Wingrove News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Patrick Wingrove. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Patrick Wingrove Today - Breaking & Trending Today

Sanofi to Cut US Price of Its Most-Prescribed Insulin by 78% - Vimarsana News

Sanofi to Cut US Price of Its Most-Prescribed Insulin by 78%

Sanofi said on Thursday it will cut US list prices for its most-prescribed insulin product, Lantus, by 78% starting next year after similar moves by rivals Novo Nordisk and Eli Lilly.

SVB fall casts shadow on early-stage U.S. biotech - Vimarsana News

SVB fall casts shadow on early-stage U.S. biotech

The collapse of Silicon Valley Bank will leave early-stage biotechnology companies with a funding void, investors and analysts said on Monday, but larger, publicly-traded drug companies should... | March 13, 2023

SVB Fall Casts Shadow on Early Stage US Biotech - Vimarsana News

SVB Fall Casts Shadow on Early Stage US Biotech

The collapse of Silicon Valley Bank will leave early stage biotechnology companies with a funding void, investors and analysts said on Monday, but larger, publicly traded drug companies should escape unscathed.

The FDA's lofty goals - POLITICO - Vimarsana News

The FDA's lofty goals - POLITICO

The White House budget request includes plans to strengthen the FDA’s regulatory authority.

Bristol Myers, Pfizer, AbbVie drugs likely to face U.S. price negotiation - Vimarsana News

Bristol Myers, Pfizer, AbbVie drugs likely to face U.S. price negotiation

The blood thinner Eliquis from Bristol Myers Squibb, Pfizer's breast cancer drug Ibrance and AbbVie's leukemia treatment Imbruvica are likely to be among 10 big-selling medicines subject to U.S.... | March 13, 2023